Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:acquired |
gptkb:Agenus_Inc.
gptkb:Ventana_Medical_Systems |
gptkbp:awards |
various industry awards
|
gptkbp:certification |
gptkb:CE_marking
gptkb:ISO_13485 FDA approval |
gptkbp:collaborations |
academic institutions
biotechnology companies pharmaceutical companies |
gptkbp:community_engagement |
research funding
education programs healthcare access initiatives |
gptkbp:customer_base |
hospitals
clinics laboratories research institutions |
gptkbp:employees |
over 10,000
|
gptkbp:financial_performance |
strong revenue growth
high profitability consistent dividends |
gptkbp:focus_area |
genetic testing
molecular diagnostics blood safety immunology clinical chemistry digital health solutions point of care testing |
gptkbp:founded |
gptkb:1896
|
gptkbp:founder |
gptkb:Fritz_Hoffmann-La_Roche
|
gptkbp:global_presence |
operates in over 100 countries
|
gptkbp:has_culture |
diversity and inclusion
employee development innovation-driven |
gptkbp:headquarters |
gptkb:Mannheim,_Germany
|
https://www.w3.org/2000/01/rdf-schema#label |
Roche Diagnostics Gmb H
|
gptkbp:industry |
healthcare
|
gptkbp:innovation |
leading in diagnostics technology
|
gptkbp:leadership |
gptkb:Board_of_Directors
CEO Severin Schwan |
gptkbp:market_share |
significant in diagnostics market
|
gptkbp:operates_in |
global market
|
gptkbp:parent_company |
gptkb:Roche_Holding_AG
|
gptkbp:part_of |
gptkb:Roche_Group
|
gptkbp:partnerships |
various healthcare organizations
|
gptkbp:products |
diagnostic tests
|
gptkbp:research_and_development |
high investment
|
gptkbp:services |
laboratory services
|
gptkbp:social_responsibility |
environmental initiatives
community support healthcare initiatives |
gptkbp:sustainability_initiatives |
social responsibility
environmental responsibility economic responsibility |
gptkbp:website |
www.roche.com
|
gptkbp:bfsParent |
gptkb:Roche_Diagnostics
|
gptkbp:bfsLayer |
4
|